Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Klein received an undergraduate degree from Cornell University in 2004, a PhD in biology from the Rockefeller University in 2011, and an MD from the Weill Cornell Medical College in 2013. He then completed a residency in internal medicine at the Brigham and Women's Hospital and Harvard Medical School in 2016 and a fellowship in Medical Oncology at Dana-Farber Cancer Institute with a clinical focus on breast cancer in 2019. Dr. Klein is a physician-scientist and practicing medical oncologist in the DFCI Breast Oncology Center and performs biomedical research at the Whitehead Institute of the Massachusetts Institute of Technology. In the laboratory, Dr. Klein studies the mechanisms of dysregulated gene expression in breast cancer, the function of the estrogen receptor, and biomolecular condensates in malignancy. He aims to use this understanding to develop more effective therapies for breast cancer. In the clinic, Dr. Klein cares for patients with both early and metastatic breast cancer, with an interest in novel therapies and personalized treatment.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions